Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.277ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.277ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.277ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.277NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.294ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.294ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.294ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.294NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.81ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
BA.2.81ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.81NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.2.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FG.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FG.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FG.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GN.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GN.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.413ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.413ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.413ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.413NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.5.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.5.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used